Son Bang Le is a notable inventor based in Gainesville, FL (US). He has made significant strides in the field of cancer treatment through his innovative research and patent contributions. His work focuses on enhancing the effectiveness of cancer therapies, particularly in overcoming resistance to treatment.

Latest Patents

Son Bang Le holds a patent for "Methods for restoring sensitivity to TTFields in TTFields-resistant cancer cells with PTGER3 inhibitors." This patent outlines methods for reducing the viability of cancer cells and preventing them from developing resistance to Tumor Treating Fields (TTFields). The invention also details how to restore sensitivity to TTFields by recommending or prescribing a PTGER3 inhibitor to a subject while applying an alternating electric field to the cancer cells. In certain cases, the sensitivity of cancer cells to TTFields can be restored using one or more PTGER3 inhibitors, such as NSAIDs or COX-2 inhibitors.

Career Highlights

Son Bang Le is currently associated with Novocure GmbH, a company dedicated to developing innovative cancer therapies. His work at Novocure has been instrumental in advancing treatment options for patients facing resistant cancer types.

Collaborations

Throughout his career, Son has collaborated with esteemed colleagues, including Dongjiang Chen and David Tran. These partnerships have fostered a collaborative environment that enhances research and development efforts in cancer treatment.

Conclusion

Son Bang Le's contributions to cancer research and treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to pave the way for advancements in the medical field, particularly in the fight against cancer.

Profile summary based on public USPTO records.